Editorial draft · writing/the-structure-of-the-receptor
The Crystal Structure of the Trip
Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.
The Crystal Structure of the Trip
“In 2017, scientists solved the crystal structure of LSD bound to its recept…”pharmacologyneuroscience
“In 2017, scientists solved the crystal structure of LSD bound to its receptor. The lid that traps the drug in place, explaining its 12-hour duration, was a protein loop nobody had anticipated.”
For most of the century since Hofmann's bicycle ride, the mechanism of LSD's action was understood in general terms, it bound to serotonin receptors, particularly 5-HT2A, but the precise structural explanation for two of its most distinctive features remained unknown: its extreme potency and its unusual duration.
LSD is active in far smaller amounts than mescaline: thousands of times less by weight for comparable effects. And where most drugs' effects follow their pharmacological half-life and clear when the drug clears, LSD's effects persist for 8-12 hours even though the drug itself metabolizes faster.
In 2017, a team led by Bryan Roth at UNC Chapel Hill published the crystal structure of LSD bound to the 5-HT2A receptor in Cell. The structure explained both mysteries at once.
On potency: LSD's molecular shape allows near-perfect complementarity with the receptor's binding pocket. The fit is so precise that even tiny amounts occupy the receptor almost completely.
On duration: a protein loop, an 'extracellular lid' formed by the receptor's second extracellular loop, closes over the LSD molecule after binding and traps it inside. The drug cannot leave until the lid opens. This explains why blocking the receptor with ketanserin before the LSD stops the effects but administering ketanserin afterward does not, the drug is locked in, and even the blocker can't reach it.
Hofmann described the intensity and duration of Bicycle Day's experience as a source of bewilderment. He'd expected the compound to metabolize more normally. The lid is why it didn't. The molecular explanation for the most famous accidental dose in pharmacological history was solved in a University of North Carolina laboratory seventy-four years after it happened.
Sources
- Wacker et al., Cell (2017)
- Hofmann, LSD: My Problem Child (1979)
- Preller & Vollenweider, Front Psychiatry (2019)
Links for this item
- Posts
- No post is recorded for this item yet.
- Source page
- The sources for this item on RN Collins Selected Work
- Long-form
- This page is the full draft.
- Gallery
- See it in the gallery index
- Project
- About this library on RN Collins Selected Work
- Corrections
- Publication rules and the correction form
Reading list for this book
- Reading list: LSD: My Problem Child Reading list
NotebookLM packs on this book
- April 19, 1943 NotebookLM source pack
Bridge pieces that use this book
- María Sabina and the Machine Elves: Two Accounts of Encountering the Other Bridge piece
- The Sacred Drug and the Dominator Drug: Hofmann and McKenna on Alcohol Bridge piece
Science annotations on this book
- A single psychedelic session can produce lasting psychological change persisting for months or years, not... Science annotation
Then vs. Now comparisons on this book
- LSD Potency: The Threshold Claim Then vs. Now comparison
- LSD and Mystical Experience: Hofmann's Claim Then vs. Now comparison
- LSD as Sacred Drug: The 1965 Prohibition Then vs. Now comparison
- Bicycle Day Chemistry: What Hofmann Synthesized Then vs. Now comparison
- LSD and the Law: Hofmann's Hope for Rescheduling Then vs. Now comparison
- LSD in Switzerland 2026: The Country That Never Stopped Then vs. Now comparison
- LSD's Crystal Structure and the Duration Mechanism Then vs. Now comparison
- Cluster Headaches and LSD: The Orphan Indication Hofmann Didn't Know About Then vs. Now comparison
- MDMA and LSD: Hofmann's Two 'Problem Children' Then vs. Now comparison
- The Neuroplasticity Mechanism: What Hofmann Couldn't Have Known Then vs. Now comparison
Claims from this book
- Mystical experience quality predicts therapeutic outcomes better than drug dose alone Claim
- Hofmann's LSD is best understood as a 'sacred drug' rather than a psychiatric tool Claim
- FDA approval of psilocybin-assisted therapy would make it broadly accessible to patients who need it Claim
- LSD is not addictive in the conventional sense, it does not produce physical dependence or compulsive use... Claim
- LSD microdosing (sub-perceptual doses) produces measurable cognitive benefits Claim
- A single psilocybin session can produce lasting reduction in tobacco addiction Claim
Other pages in this library that link here
- What is the primary mechanism of action of classical psychedelics? Flashcard
- What is functional selectivity at the 5-HT2A receptor and why does it matter therapeutically? Flashcard
- The First Contacts Course module
- The Science of the Experience Course module
- The Suppression Course module
- Psychedelic Science for Science Writers Teaching module